Global Kidney Academy

Today is #IgANAwarenessDay! Take a deeper look at IgA nephropathy through expert-led programs exploring KDIGO recommendations, proteinuria reduction strategies, shared decision-making, and more: globalkidneyacademy.org/disease-state/… #Nephrology #IgAN #KidneyHealth

How do you manage #hyperkalemia without compromising guideline-directed medical therapy in #heartfailure? A recent case highlights the challenge: stopping MRAs may normalize potassium but can worsen HF symptoms. Learn how potassium binders can help: globalkidneyacademy.org/u/18791

Are antihistamines addressing the root cause of itch in CKD-aP? Emerging evidence shows CKD-associated pruritus is driven by non-histaminergic pathways, raising questions about traditional approaches. Explore the evolving science: globalkidneyacademy.org/u/18721 #Nephrology #CKDaP

Beyond dermatologic manifestations, CKD-aP contributes to a cascade of symptoms affecting sleep quality, mental health, and daily functioning. Recognizing these interconnected effects is critical in clinical practice. Learn more: globalkidneyacademy.org/u/18660 #Nephrology

How do you guide patients with IgA nephropathy through complex treatment decisions? This CE activity explores shared decision-making, risk communication, and aligning care with patient priorities: globalkidneyacademy.org/u/18574 #IgAN #Nephrology #CME

How often does hyperkalemia limit your ability to optimize RAAS inhibitors? This case-based discussion breaks down practical strategies to manage risk while maintaining guideline-directed medical therapy: globalkidneyacademy.org/u/18543 #Hyperkalemia #CardioRenal #MedEd

#NationalKidneyMonth wraps up, but CKD-aP still deserves attention. This CME activity reviews the mechanisms behind CKD-associated pruritus, new European S2k guidelines, KALM study biomarker findings, and more: reachmd.com/u/18509 #Nephrology #MedicalEducation

March is #NationalKidneyMonth. This CME activity features Professor Jonathan Barratt in a real patient interaction, covering the Oxford MEST-C score, emerging treatment options, and practical shared decision-making in #IgAN care: globalkidneyacademy.org/u/18455 #Nephrology #MedEd

#NationalKidneyMonth continues. #Hyperkalemia complicates GDMT optimization in patients with #CKD and heart failure, yet potassium binder use remains low in clinical practice. Review KDIGO guidance, and examine emerging data: globalkidneyacademy.org/u/18427 #Nephrology #MedicalEducation

Does CKD-aP require ongoing treatment? Clinical experience across Europe suggests itch may return after dose reduction or discontinuation. Review long-term management insights this #WorldKidneyDay2026: globalkidneyacademy.org/u/18284 #NationalKidneyMonth #OurKidneysOurPlanet

In recognition of National Kidney Month, tune in to this expert discussion on the epidemiology, pathophysiology, clinical burden, and management of CKD-aP: globalkidneyacademy.org/u/18258 #CKDaP #NationalKidneyMonth #OurKidneysOurPlanet #KidneyHealthForAll

On #RareDiseaseDay, we recognize #IgAnephropathy (IgAN). Drs. Jonathan Barratt and Sydney Tang review updated guidelines and real-world data on combination therapy with a dual endothelin–angiotensin receptor antagonist and SGLT2 inhibitors: globalkidneyacademy.org/u/18314 #Nephrology

Over 30% of patients on hemodialysis experience moderate to severe CKD-associated pruritus. Are we recognizing it in practice? Review the prevalence and clinical impact of this condition: globalkidneyacademy.org/u/18215 #Nephrology #CKD #Dialysis

A complex patient case highlights the overlap between #CKD, #diabetes, and #heartfailure, and the challenge of adhering to guideline therapy when potassium levels rise. Check out the full discussion for clinical context and expert insights: globalkidneyacademy.org/u/18146 #MedEd

CKD-associated pruritus is often underrecognized, yet it has a significant impact on patients receiving hemodialysis. How can clinicians consistently assess itch severity and its effect on quality of life in everyday practice? Hear from leading experts: globalkidneyacademy.org/u/18092

Hear experts discuss current guideline recommendations for managing iron deficiency in heart failure, including when to use IV iron: globalkidneyacademy.org/u/18051 #Cardiology #Nephrology #HeartFailure

Routine screening for CKD-associated pruritus using validated tools helps identify symptoms patients may not report on their own. How can this be implemented in dialysis care? Hear more insights: globalkidneyacademy.org/u/17982 #nephrology #CKD

Dr. Jürgen Floege reviews key updates in the KDIGO 2025 guideline for IgA nephropathy that may shift how we approach risk assessment and long-term disease management: globalkidneyacademy.org/disease-state/… #KDIGO2025 #IgAN #Nephrology #KidneyHealth

Are you integrating the updated @goKDIGO guidelines into your treatment approach for IgA nephropathy? Gain actionable insights on identifying high-risk patients with #IgAN and tailoring treatment: globalkidneyacademy.org/cme/nephrology… #Nephrology #ChronicKidneyDisease #Proteinuria

Dr. Ellie Kelepouris breaks down a key clinical dilemma, highlighting KDIGO 2024 & European Society 2025 guidance to continue RAASi when possible. Learn how patiromer & SZC manage hyperkalemia in CKD & HF—while balancing sodium risk. ow.ly/3eIV50XLphW